Apogee Therapeutics, Inc. APGE Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Apogee Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Apogee Therapeutics, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Apogee Therapeutics, Inc.'s shares (diluted)?
- Apogee Therapeutics, Inc. (APGE) reported shares (diluted) of 69.7M in Q1 2026.
- How has Apogee Therapeutics, Inc.'s shares (diluted) changed year-over-year?
- Apogee Therapeutics, Inc.'s shares (diluted) increased by 19.7% year-over-year, from 58.2M to 69.7M.
- What is the long-term trend for Apogee Therapeutics, Inc.'s shares (diluted)?
- Over 2 years (2023 to 2025), Apogee Therapeutics, Inc.'s shares (diluted) has grown at a 76.0% compound annual growth rate (CAGR), from 76.2M to 236.1M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.